Kilbridge Peter M, Noirot Laura A, Reichley Richard M, Heard Kevin M, Dunagan Wm Claiborne, Bailey Thomas C
Washington University School of Medicine and BJC HealthCare, St. Louis, MO, USA.
AMIA Annu Symp Proc. 2008 Nov 6:1004.
Adverse drug event (ADE) surveillance is needed to inform processes and methods for prevention. Voluntary reporting and manual chart review have limitations. Automated surveillance systems are gaining recognition and provide useful information to supplement the other methods. Preliminary evaluation of a pediatric automated adverse drug event application shows a positive predictive value of 13%, discovering events with harm in 1.3% of inpatient admissions.
需要进行药物不良事件(ADE)监测,以便为预防流程和方法提供信息。自愿报告和人工病历审查存在局限性。自动化监测系统正逐渐得到认可,并能提供有用信息以补充其他方法。一项儿科自动化药物不良事件应用的初步评估显示,其阳性预测值为13%,在1.3%的住院患者中发现了有危害的事件。